Form 8-K - Current report:
SEC Accession No. 0001558370-24-009621
Filing Date
2024-06-28
Accepted
2024-06-28 16:30:18
Documents
13
Period of Report
2024-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20240626x8k.htm   iXBRL 8-K 58872
  Complete submission text file 0001558370-24-009621.txt   184491

Data Files

Seq Description Document Type Size
2 EX-101.SCH krbp-20240626.xsd EX-101.SCH 3405
3 EX-101.LAB krbp-20240626_lab.xml EX-101.LAB 16578
4 EX-101.PRE krbp-20240626_pre.xml EX-101.PRE 10531
17 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20240626x8k_htm.xml XML 5025
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 241086156
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)